Regina Salvat
Papers
2
Total Citations
28
H-Index
2
About
Regina Salvat is a researcher whose work sits at the critical intersection of immunology and high-throughput biotechnology, with a primary focus on peptide-MHC II binding assays. Her major contribution is the development of a scaled-down, 384-well format biochemical assay that enables rapid, quantitative analysis of immunogenic epitopes. This innovation directly addresses a key bottleneck in vaccine design and autoimmune disease research: the need for efficient, cost-effective screening of peptide-MHC interactions. By reducing reagent costs by 75%, her protocol makes high-throughput epitope identification, deletion, and design far more accessible to the broader research community. Her most-cited work, a 2014 paper detailing this method, has garnered 21 citations, underscoring its utility and impact in the field. This achievement highlights her ability to translate complex immunological principles into practical, scalable tools that accelerate discovery. For students and researchers in immunology or assay development, Salvat’s work exemplifies how method refinement can drive progress, offering a template for balancing throughput, cost, and quantitative rigor in epitope mapping.
Research Focus
Key Achievements
Top Papers
- 1
- 2